首页> 外文学位 >Effects of inhibiting CDK9 on the expression of primary response genes.
【24h】

Effects of inhibiting CDK9 on the expression of primary response genes.

机译:抑制CDK9对初级反应基因表达的影响。

获取原文
获取原文并翻译 | 示例

摘要

Flavopridol (FVP) is a well known pharmacological inhibitor of Cyclin Dependent Kinases (CDKs), with significant selectivity for Cyclin Dependent Kinase 9 (CDK9). Treatment of cells with FVP results in inhibition of transcription elongation. CDK9 is a serine/threonine kinase that associates with T-type cyclins. These complexes are designated transcription elongation factors (P-TEFb). P-TEFb controls transcription elongation by phosphorylating the carboxyl terminal domain (CTD) of RNA polymerase II (RNAPII) and negative elongation factors. Whether P-TEFb is required for the elongation of most genes transcribed by RNAPII or fraction of them is still debatable. The aim of my Thesis is to understand the early and late effects of FVP on primary response gene expression. Two different microarray analyses with RNA probes obtained from T98G and BJ-TERT cells were performed by Drs. Grana and Garriga to determine the effect of inhibiting CDK9 on global mRNA expression using a dominant negative mutant of CDK9 (dnCDK9) and FVP.;These gene profiling experiments showed that FVP and dnCDK9 downregulate the expression of several genes. However, these studies also showed upregulation of a group of primary response genes (PRGs). The goal of this thesis was to bring some light into this unexpected phenomenon. I have found that several PRGs including FOS, JUNB, EGR1 and GADD45B, are rapidly and potently downregulated before they are upregulated upon FVP treatment in exponentially growing cells. In serum starved cells restimulated with serum, FVP also inhibits the expression of these genes, but subsequently, JUNB, GADD45B and EGR1 are upregulated in the presence of FVP. Chromatin Immunoprecipitation of RNAPII revealed that EGR1 and GADD45B are apparently transcribed at the FVP-treatment time points where their corresponding mRNAs accumulate. These results suggest a possible stress response triggered by CDK9 inhibition. I also show that serum starvation does not affect the localization of RNAPII immediately downstream of the promoter of a PRG where RNAPII remains paused in the absence of mitogenic stimulation, suggesting that initiation is not rate limiting for transcription of at least certain PRGs in the absence of mitogens and remains dependent on transcription elongation.;In sum, I have shown that certain PRG/IRGs are transcribed in the presence of FVP and their transcription might be independent of CDK9 suggesting a possible alternative mechanism of their transcription. I also determined that transcription initiation is not affected by serum starvation, as paused RNAPII appears to remain bound downstream of a PRG promoter in quiescent cells independently of the length of mitogenic starvation.
机译:Flavopridol(FVP)是众所周知的细胞周期蛋白依赖性激酶(CDKs)的药理抑制剂,对细胞周期蛋白依赖性激酶9(CDK9)具有明显的选择性。用FVP处理细胞导致转录伸长的抑制。 CDK9是与T型细胞周期蛋白相关的丝氨酸/苏氨酸激酶。这些复合物称为转录延伸因子(P-TEFb)。 P-TEFb通过磷酸化RNA聚合酶II(RNAPII)的羧基末端结构域(CTD)和负伸长因子来控制转录伸长。是否需要P-TEFb来延长大多数由RNAPII转录的基因或它们的一部分是尚待商bat。本论文的目的是了解FVP对主要反应基因表达的早期和晚期影响。 Drs使用从T98G和BJ-TERT细胞获得的RNA探针进行了两种不同的微阵列分析。 Grana和Garriga使用CDK9(dnCDK9)和FVP的显性负突变确定抑制CDK9对全局mRNA表达的影响;这些基因谱分析实验表明FVP和dnCDK9下调了几个基因的表达。但是,这些研究也显示了一组主要反应基因(PRG)的上调。本文的目的是为这种意外现象提供一些启示。我发现包括FOS,JUNB,EGR1和GADD45B在内的几种PRG在经过FVP处理后在呈指数增长的细胞中迅速而有效地被下调。在用血清再刺激的血清饥饿的细胞中,FVP也抑制这些基因的表达,但随后,在存在FVP的情况下,JUNB,GADD45B和EGR1被上调。 RNAPII的染色质免疫沉淀显示EGR1和GADD45B明显在FVP处理的时间点转录,在该时间点它们的相应mRNA积累了。这些结果表明可能由CDK9抑制触发应激反应。我还表明,血清饥饿不会影响RNA聚合酶II在PRG启动子下游的定位,其中在没有促有丝分裂刺激的情况下,RNAP II仍处于暂停状态,这表明启动没有限制至少某些PRG转录的速率。总而言之,我已经证明某些PRG / IRG在FVP存在下被转录,它们的转录可能独立于CDK9,提示它们可能是转录的替代机制。我还确定转录启动不受血清饥饿的影响,因为暂停的RNAPII似乎仍然结合在静止细胞中PRG启动子的下游,而与有丝分裂饥饿的长度无关。

著录项

  • 作者

    Keskin, Havva.;

  • 作者单位

    Temple University.;

  • 授予单位 Temple University.;
  • 学科 Biology Molecular.
  • 学位 M.S.
  • 年度 2011
  • 页码 86 p.
  • 总页数 86
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号